ClinVar Miner

Submissions for variant NM_000035.4(ALDOB):c.178C>T (p.Arg60Ter)

gnomAD frequency: 0.00010  dbSNP: rs118204429
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 15
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000000501 SCV000220395 likely pathogenic Hereditary fructosuria 2014-06-10 criteria provided, single submitter literature only
GeneDx RCV000760464 SCV000890352 pathogenic not provided 2022-09-06 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Also reported as R59X due to alternate nomenclature; This variant is associated with the following publications: (PMID: 25525159, 8299883, 8071980, 26937407, 15880727, 27604308, 20882353, 20033295, 8299892, 35398868, 18541450)
Fulgent Genetics, Fulgent Genetics RCV000000501 SCV000894462 pathogenic Hereditary fructosuria 2021-11-08 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000000501 SCV000916436 pathogenic Hereditary fructosuria 2017-11-09 criteria provided, single submitter clinical testing Variant summary: The ALDOB c.178C>T (p.Arg60X) variant results in a premature termination codon, predicted to cause a truncated or absent ALDOB protein due to nonsense mediated decay, which are commonly known mechanisms for disease. This variant was found in 20/277036 control chromosomes (gnomAD) at a frequency of 0.0000722, which does not exceed the estimated maximal expected allele frequency of a pathogenic ALDOB variant (0.0044721). Multiple publications have cited the variant in affected compound heterozygote and homozygote patients. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as pathogenic.
Invitae RCV000000501 SCV000964566 pathogenic Hereditary fructosuria 2024-01-18 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg60*) in the ALDOB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDOB are known to be pathogenic (PMID: 18541450). This variant is present in population databases (rs118204429, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with hereditary fructose intolerance (PMID: 8071980, 8299883, 15880727, 20882353, 26937407). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 472). For these reasons, this variant has been classified as Pathogenic.
Genome-Nilou Lab RCV000000501 SCV001810254 pathogenic Hereditary fructosuria 2021-07-22 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000000501 SCV002024916 pathogenic Hereditary fructosuria 2022-01-26 criteria provided, single submitter clinical testing
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV002251843 SCV002523704 pathogenic See cases 2019-05-09 criteria provided, single submitter clinical testing ACMG classification criteria: PVS1, PM2, PM3, PP3, PP5
Ambry Genetics RCV002512606 SCV003528888 pathogenic Inborn genetic diseases 2022-04-21 criteria provided, single submitter clinical testing The c.178C>T (p.R60*) alteration, located in exon 3 (coding exon 2) of the ALDOB gene, consists of a C to T substitution at nucleotide position 178. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 60. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.0085% (24/282704) total alleles studied. The highest observed frequency was 0.01% (4/35438) of Latino alleles. This alteration has been reported in multiple patients with hereditary fructose intolerance (Brooks, 1994; Santer, 2005; Davit-Spraul, 2008; Valadares, 2015; Kim, 2021). Based on the available evidence, this alteration is classified as pathogenic.
PreventionGenetics, part of Exact Sciences RCV003407248 SCV004113432 pathogenic ALDOB-related condition 2023-05-16 criteria provided, single submitter clinical testing The ALDOB c.178C>T variant is predicted to result in premature protein termination (p.Arg60*). This variant has been reported to be causative for hereditary fructose intolerance (Brooks et al. 1994. PubMed ID: 8299883; Valadares et al. 2015. PubMed ID: 26937407; Reid et al. 2016. PubMed ID: 27604308; Kim et al. 2021. PubMed ID: 33028743). Note, this is also referred to as R59op, Arg59Ter, and Arg60Ter in some literature. This variant is reported in 0.011% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-104192183-G-A). Nonsense variants in ALDOB are expected to be pathogenic. This variant is interpreted as pathogenic.
Baylor Genetics RCV000000501 SCV004196071 pathogenic Hereditary fructosuria 2023-10-31 criteria provided, single submitter clinical testing
OMIM RCV000000501 SCV000020650 pathogenic Hereditary fructosuria 1994-06-01 no assertion criteria provided literature only
GeneReviews RCV000000501 SCV000257568 not provided Hereditary fructosuria no assertion provided literature only One of the six most common HFI variants in US and European populations including Turkey, Spain, Central Europe, France, US, and Italy
Natera, Inc. RCV000000501 SCV001462846 pathogenic Hereditary fructosuria 2020-09-16 no assertion criteria provided clinical testing
ATS em Genética Clínica, Universidade Federal do Rio Grande do Sul RCV000000501 SCV001573831 likely pathogenic Hereditary fructosuria 2021-03-18 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.